Prevention of contrast nephropathy in patients undergoing coronary angiography or angioplasty

Phase 2

• Conditions: Contrast medium Nephropathy.; Nephropathy induced by unspecified drug, medicament or biological substance

• Registration Number: IRCT2015061422713N1
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 51

Inclusion Criteria

The patients undergoing angiography or angioplasty due to elevated acute coronary syndrome (Non-ST Elevation Myocardial Infarction); Patients who have risk score more than 6, based on Mehran studies.

Exclusion criteria: Patients undergoing ST Elevation Myocardial Infarction; Patients undergoing cardiogenic shock; Patients with severe heart failure (NYHA class 3 or 4, or left ventricular ejection fraction less than 30%) that do not tolerate mentioned protocol of treatment fluid; Kidney transplant patients or patients undergoing dialysis; Patients who receive contrast cronary substance a week before angiography or angioplasty; Patients who can not stand cuff inflation for 5 minutes; Patients with bleeding disorders so that they suffered at least 1 gram per deciliter Hb falling.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Failure caused by Contrast medium (CIN). Timepoint: 24 to 48 hours after angiography or angioplasty. Method of measurement: Blood test.;Blood creatinine level. Timepoint: 24 to 48 hours after angiography or angioplasty. Method of measurement: Blood test.